Berlin-based FEMNA Health, an e-health brand specializing in female health, has successfully secured seven-figure growth funding from both existing and new strategic investors. The company’s innovative approach in addressing menstrual health issues and enhancing women’s health services has attracted substantial interest from Berlin Angel Fund, Atreyu Investments, Cimexia GmbH, and IBB Capital GmbH, supported by the KfW/IBB program “BerlinInnoGrowth”. Additionally, the new financial support will allow FEMNA Health to expand its digital platform, broaden its range of therapies, and promote educational initiatives in the women’s health field.
In recent times, FEMNA Health has consistently taken strides in enhancing women’s health services. Past reports highlighted the company’s early achievements in telemedicine, providing convenient access to medical professionals for advice on various women’s health issues. FEMNA’s growth trajectory has shown a steady increase in user engagement and an expanding product line aimed at addressing specific needs like menstrual disorders and menopausal concerns. These developments position FEMNA Health strongly in the competitive e-health market.
Founded by Maxie Matthiessen, FEMNA Health is a telemedicine platform dedicated to women’s hormonal health. The platform facilitates easy access to medical doctors and naturopaths, offering detailed advice and therapeutic recommendations. The services cover a wide range of topics, from menstrual disorders to family planning and menopausal issues, catering to women aged 25 to 45.
Innovative Health Solutions
With the new funding, FEMNA Health plans to enhance its offerings by developing innovative solutions for menstrual health issues, broadening its range of therapies, and improving its digital platform. These improvements aim to provide more comprehensive and accessible health care solutions for women, empowering them to take control of their health.
Expanding Digital Platform
FEMNA Health’s digital platform is designed to offer virtual consultations with naturopaths and doctors, utilizing diagnostics through home testing kits. The company also offers a proprietary and unique product line tailored to meet the specific needs and desires of its customers. Since its inception in 2016, FEMNA Health has served 14,000 women, offering natural treatment options and reducing reliance on conventional gynecological visits.
The company’s approach to women’s health emphasizes natural treatments and detailed consultations, which stand in contrast to the often superficial treatments provided by OB-GYN doctors with birth control pills. FEMNA Health’s solutions empower women to take proactive steps in managing their health, providing alternatives that are more aligned with their individual needs.
The significant growth funding secured by FEMNA Health underlines the increasing recognition of the importance of specialized women’s health services. The company’s innovative solutions and strategic expansions are set to make a significant impact on the e-health sector. By continuing to develop its digital platform and expanding its range of therapies, FEMNA Health is poised to offer even more comprehensive care, potentially benefiting a wider demographic of women.
